SUZ12 抗体 (C-Term)
Quick Overview for SUZ12 抗体 (C-Term) (ABIN4889655)
抗原
See all SUZ12 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- C-Term
-
纯化方法
- Affinity Purified
-
免疫原
- This Suz12 antibody was raised against a peptide corresponding to the C-terminus of human Suz12.
-
亚型
- IgG
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 0.56 μg/μL
-
缓冲液
- 70 mM Tris ( pH 8), 105 mM NaCl, 31 mM glycine, 0.07 mM EDTA, 30 % glycerol, and 0.035 % sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
-
Avoid repeated freeze/thaw cycles and keep on ice when not in storage.
-
储存条件
- -20 °C
-
储存方法
- Antibodies in solution can be stored at -20 °C for 2 years.
-
有效期
- 6 months
-
-
-
: "LANA-Mediated Recruitment of Host Polycomb Repressive Complexes onto the KSHV Genome during De Novo Infection." in: PLoS pathogens, Vol. 12, Issue 9, pp. e1005878, (2016) (PubMed).
: "Retinoic acid controls body axis extension by directly repressing Fgf8 transcription." in: Development (Cambridge, England), Vol. 141, Issue 15, pp. 2972-7, (2014) (PubMed).
: "In situ histone landscape of nephrogenesis." in: Epigenetics, Vol. 9, Issue 2, pp. 222-35, (2014) (PubMed).
: "Cis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14 (+) monocytes and CD34 (+) cells." in: PLoS pathogens, Vol. 9, Issue 5, pp. e1003366, (2013) (PubMed).
-
: "LANA-Mediated Recruitment of Host Polycomb Repressive Complexes onto the KSHV Genome during De Novo Infection." in: PLoS pathogens, Vol. 12, Issue 9, pp. e1005878, (2016) (PubMed).
-
- SUZ12 (SUZ12 Polycomb Repressive Complex 2 Subunit (SUZ12))
-
别名
- Suz12
-
分子量
- 95 kDa
-
基因ID
- 23512
抗原
-